NTRS vs OCUL · P/E 18, rev $2.69B vs rev $24.3M
Northern Trust Corporation (NTRS) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the NTRS and OCUL stock pages for the full models.
Not investment advice.